China' Sinopec First-Quarter Profit Beats Forecast, Outlook Is Rosy

Top Asian oil refiner Sinopec beat forecasts with a more than two-fold jump in quarterly earnings as falling oil prices helped its refining arm turn around, and it flagged a 50% surge in first-half profit.

Now with oil prices likely to hold steady or even soften this year, investors foresee double-digit net profit growth for Sinopec in 2007. But its fortunes also hinge on whether Beijing allows it to charge more for refined products.

State-run Sinopec said this month it expected net profit to rise more than half in the first quarter -- but based on Chinese accounting standards -- after its refining arm returned to profits in the fourth quarter of 2006.

Global crude oil prices plunged to a 19-month low of $51 a barrel in January before rebounding to around $65 a barrel at the end of March.

Sinopec, which vies with PetroChina and CNOOC to supply the world's second largest oil market, said its net profit was 19.4 billion yuan ($2.5 billion) in the first three months versus a revised 9.55 billion yuan a year earlier. The result beat a forecast for 18 billion yuan, according to three analysts polled by Reuters.

A top economic planning official said last month China would adopt a cautious approach in reforming energy prices, to better suit international levels.

Sinopec, also China's second-largest oil and gas producer, pumped 2.3% more crude and 15.6% more natural gas in 2006. It processed 146.32 million tons of crude last year, up 4.6% from a year earlier.

Shares in Sinopec fell 8% in the January to March period, outperforming PetroChina's 16% fall but lagging CNOOC's 7% drop.

Sinopec trades at 9.5 times forecast earnings, cheaper than Exxon Mobil's 12.2 and BP's 11.



  • The Marriner S. Eccles Federal Reserve building in Washington.

    CNBC's Fed Survey shows market pros aren't very confident the Fed can end its easy money polices without a market crash, a recession or bad inflation.

  • Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Merck reported better-than-expected results, with sales of newer drugs offsetting declining sales of drugs facing generic competition.

  • Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

  • An attendee is silhouetted against a Microsoft poster at the Microsoft Developers Build Conference in San Francisco, April 2, 2014.

    An agency that enforces antimonopoly laws visited company offices in four cities, as the country more closely scrutinizes multinational companies.

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video